528PAFLIBERCEPT + FOLFIRI FOR TREATMENT OF METASTATIC COLORECTAL CANCER AFTER OXALIPLATIN FAILURE: 4TH INTERIM SAFETY DATA FROM THE GLOBAL AFLIBERCEPT SAFETY AND QUALITY-OF-LIFE PROGRAM (ASQOP/AFEQT STUDIES).
暂无分享,去创建一个
V. Heinemann | J. Taieb | A. Sobrero | Anne L. Thomas | G. Lledo | R. Bordonaro | L. Frassineti | M. Bartolomeo | C. Zilocchi | Y. Moore | S. Brette